KCC Precedent Search Options

KCC's Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results.

For information about the data provided, please review the Disclaimer statement.


General Information:

On September 15 and 16, 2019, Purdue Pharma L.P. and its affiliated debtors (collectively, “Purdue”) filed voluntary petitions for relief under chapter 11 of the United States Bankruptcy Code. Purdue’s cases are jointly administered under Case No. 19-23649 before the Honorable Sean H. Lane in the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court").

On September 26, 2019, the United States Trustee for Region 2 appointed nine creditors to serve on the Official Committee of Unsecured Creditors (the “UCC”). The UCC is an independent fiduciary for and represents the interests of all creditors in Purdue’s cases.

Plan of Reorganization and Related Appeals:

On June 3, 2021, the Bankruptcy Court entered an order approving the disclosure statement and solicitation procedures related to Purdue’s proposed Plan of Reorganization (the “Plan”). On September 17, 2021, the Bankruptcy Court issued a decision and order confirming the Plan (the “Confirmation Order”). Certain parties appealed the Confirmation Order, and on December 16, 2021, the District Court presiding over these appeals issued a decision (the “District Court Decision”) reversing the Bankruptcy Court and vacating the Confirmation Order. Purdue, the UCC and other creditor groups supporting the Plan then appealed the District Court Decision to the U.S. Court of Appeals for the Second Circuit (the “Second Circuit”). On May 30, 2023, the Second Circuit issued an opinion reversing the District Court Decision, affirming the Confirmation Order and remanding the case to the District Court for further proceedings.

More information regarding Purdue’s cases may be found at the following webpage: https://purduepharmaclaims.com.

If you would like to ask questions of the UCC, please call (888) 647-1738 (U.S./Canada) or (310) 751-2625 (International) or click here to submit an email inquiry..

Important Dates, Deadlines & Documents Show All Dates

December 13, 2023
(11:00 AM (ET))

November 15, 2023
(11:00 AM (ET))

October 18, 2023
(11:00 AM (ET))

September 20, 2023
(11:00 AM (ET))

August 16, 2023
(11:00 AM (ET))

July 20, 2023
(11:00 AM (ET))

July 30, 2020
(5:00 PM (ET))

November 5, 2019
(10:00 AM (ET))

September 15 and 16, 2019


Debtor Name
Debtor Case Number
Purdue Pharma Inc.
Purdue Pharma L.P.
Purdue Transdermal Technologies L.P.
Purdue Pharma Manufacturing L.P.
Purdue Pharmaceuticals L.P.
Imbrium Therapeutics L.P.
Adlon Therapeutics L.P.
Greenfield BioVentures L.P.
Seven Seas Hill Corp.
Ophir Green Corp.
Purdue Pharma of Puerto Rico
Avrio Health L.P.
Purdue Pharmaceutical Products L.P.
Purdue Neuroscience Company
Nayatt Cove Lifescience Inc.
Button Land L.P.
Paul Land Inc.
Quidnick Land L.P.
Rhodes Associates L.P.
Rhodes Pharmaceuticals L.P.
Rhodes Technologies
SVC Pharma LP
SVC Pharma Inc.

Meeting of Creditors

The meeting of creditors pursuant to section 341 of the Bankruptcy Code (the "Meeting of Creditors") occurred on November 5, 2019 at 2:30 p.m. (ET) at the below location.

United States Bankruptcy Court
Southern District of New York
One Bowling Green (Room 511)
New York, NY 10004-1408

Rule 9001(5) of the Federal Rules of Bankruptcy Procedure requires that a representative of the Debtor appear at the Meeting of Creditors for the purpose of being examined under oath by a representative of the Office of the United States Trustee and by any interested parties that attend the meeting. Creditors are welcome, but not required, to attend the meeting. The Meeting of Creditors may be continued or adjourned by notice at the meeting, without further written notice to creditors.

Court Address and Location to File Proofs of Claim

Court Address

United States Bankruptcy Court
Southern District of New York
300 Quarropas Street, Room 248
White Plains, NY 10601
T: (914) 467-7250

Location to File Proof(s) of Claim

If by first class mail:
Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
Grand Central Station, PO Box 4850
New York, NY 10163-4850

If by hand delivery, or overnight courier:
Purdue Pharma Claims Processing Center
c/o Prime Clerk LLC
850 3rd Avenue, Suite 412
Brooklyn, NY 11232

Please file proof(s) of claim, if any, via US Mail or other hand delivery system. Facsimile and other electronic delivery methods are not acceptable. You must file an originally executed proof of claim. If you would like a copy of your claim returned to you as proof of receipt, please enclose an additional copy and a self-addressed postage-paid envelope.

Committee Advisors

Lead Counsel to the Official Committee of Unsecured Creditors
Akin Gump Strauss Hauer & Feld LLP
One Bryant Park
New York, NY 10036
T: (212) 872-1000
F: (212) 872-1002
Ira S. Dizengoff, Esq.
Arik Preis, Esq.
Mitchell Hurley, Esq.
Sara L. Brauner, Esq.

Efficiency Counsel to the Official Committee of Unsecured Creditors
Cole Schotz, P.C.
500 Delaware Avenue, Suite 1410
Wilmington, Delaware 19801
T: (302) 655-5000
F: (302) 658-6395
Justin R. Alberto, Esq.

Financial Advisor to the Official Committee of Unsecured Creditors
Province, Inc.
36 S. Charles St. Suite 2310
Baltimore, MD 21201
T: (702) 685-5555
Michael Atkinson

Investment Banker to the Official Committee of Unsecured Creditors
Jefferies LLC
520 Madison Avenue
New York, NY 10022
Leon Szlezinger

Noticing and Information Agent
Kurtzman Carson Consultants LLC (“KCC”)
222 N. Pacific Coast Highway, Suite 300
El Segundo, CA 90245
(888) 647-1738